-
-
-
-
-
-
-
Johnson & Johnson faces $32 million verdict in Los Angeles asbestos case
-
-
-
-
-
-
-
Leerink Partners Upgrades Johnson & Johnson (JNJ) to Outperform
-
-
-
-
-
-
-
Johnson & Johnson presents CAPLYTA analysis for depression treatment
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $283 at Morgan Stanley
-
-
-
-
-
-
-
Johnson & Johnson beats estimates, raises 2026 guidance
-
-
-
-
-
-
-
TD Cowen Assumes Johnson & Johnson (JNJ) at Buy
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ)
-
417,537 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

